Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 609
Selected: 0
NCT IDTitle
NCT03598309Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
NCT00802932Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx
NCT02502864Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide
NCT03026699Refining and Testing the Electronic Social Network Assessment Program (eSNAP)
NCT02032810Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
NCT02631590Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
NCT01823991COGNUTRIN in Breast Cancer Survivors
NCT04585269Bright IDEAS - Young Adults Problem-Solving Skills Training
NCT00226577Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.
NCT01795573Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease
NCT03411031Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide
NCT02851056Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
NCT05763563Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy
NCT01534078Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma
NCT02450708Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
NCT02300610Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
NCT00005615Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa
NCT05054218COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients
NCT07576842Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
NCT03758781IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
NCT03807765Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
NCT01713400Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
NCT01024387AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
NCT02935309Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
NCT05093608SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma
NCT00786760Natural History of HPV Infection in Men: The HIM Study
NCT07018986The MIND-BC Study: MIND Diet for Breast Cancer Cognition
NCT01008527Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100
NCT05064423Clinical Trials Outreach & Education
NCT05004662Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers
NCT01671813Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly
NCT01531205Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
NCT01455311Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors
NCT03295695PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient
NCT02276664Capitalizing on a Teachable Moment to Promote Smoking Cessation
NCT04526730Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
NCT07194044Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
NCT01253161Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
NCT01432574Study of Gardasil in Mid-Adult Males (MAM)
NCT01701674Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
NCT01176474Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
NCT00005624CI-994 in Treating Patients With Advanced Myeloma
NCT01754623GTX-RT in Borderline Resectable Pancreatic Cancer
NCT02218164Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
NCT04980157CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
NCT00005611BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment
NCT04101422Utilizing Augmented Reality as an Adjunct for Smoking Cessation
NCT00704054A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)
NCT02745756A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
NCT02509416Rapid Assessment of Trainee Endoscopy Skills (RATES) Study Two